Skip to Main Content

Paper Details

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.
Genet Med
2
2019
Author NameAffiliation
Adrian ThorogoodMcGill University
Yann JolyMcGill University
Bartha Maria KnoppersMcGill University
  • 1 - 3

Datasets

Release 1.2